牛牛AI助理已提取核心訊息
Sally Susman, Executive Vice President at Pfizer Inc. [PFE], was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Susman after the action. This transaction is part of the routine disclosures that executive officers are required to make and could be of interest to investors following Pfizer's stock.
Sally Susman, Executive Vice President at Pfizer Inc. [PFE], was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Susman after the action. This transaction is part of the routine disclosures that executive officers are required to make and could be of interest to investors following Pfizer's stock.
據報道，輝瑞公司 [PFE] 執行副總裁薩利·蘇斯曼於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露交易的具體細節，包括行動類型、狀態、股票數量、股票性質、交易價格和股票總價值。該報告沒有提供有關蘇斯曼在行動後持有的股票數量的信息。該交易是執行官必須進行的例行披露的一部分，關注輝瑞股票的投資者可能會對此感興趣。
據報道，輝瑞公司 [PFE] 執行副總裁薩利·蘇斯曼於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露交易的具體細節，包括行動類型、狀態、股票數量、股票性質、交易價格和股票總價值。該報告沒有提供有關蘇斯曼在行動後持有的股票數量的信息。該交易是執行官必須進行的例行披露的一部分，關注輝瑞股票的投資者可能會對此感興趣。
有用
沒用